A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells

A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells N-Aryltriazole ribonucleosides with potent antiproliferative activity against drug-resistant pancreatic cancer Novel Triazole Ribonucleoside Down-Regulates Heat Shock Protein 27 and Induces Potent Anticancer Activity on Drug-Resistant Pancreatic Cancer Discovery of Novel Arylethynyltriazole Ribonucleosides with Selective and Effective Antiviral and Antiproliferative Activity Identification of a C3′-nitrile nucleoside analogue inhibitor of pancreatic cancer cell line growth Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication The Flavonoid Apigenin Potentiates the Growth Inhibitory Effects of Gemcitabine and Abrogates Gemcitabine Resistance in Human Pancreatic Cancer Cells Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides Synthesis and antitumor activity of novel 2′,3′-diethanethio-2′,3′,5′-trideoxy-5′-triazolonucleoside analogues